Rare cases of Guillain-Barr é syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021
ConclusionThree and four times more GBS cases than expected were reported after vaccination with Vaxzevria and COVID-19 Vaccine Janssen, respectively, therefore GBS might be an adverse event of vector-based vaccines. Bifacial paresis was more common in cases with GBS following vaccination with vector-based than mRNA COVID-19 vaccines.
Source: Eurosurveillance - Category: Infectious Diseases Authors: Helmar C Lehmann, Doris Oberle, Brigitte Keller-Stanislawski, Thorsten Rieck and Renz Streit Source Type: research
More News: Covid Vaccine | COVID-19 | European Medicines Agency (EMA) | Flu Pandemic | Germany Health | Guillain-Barr Syndrome | Infectious Diseases | Influenza | Influenza Vaccine | Pandemics | Vaccines